Healthia Limited

ASX:HLA Rapporto sulle azioni

Cap. di mercato: AU$252.1m

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Healthia Gestione

Gestione criteri di controllo 3/4

Healthia's Il CEO è Wes Coote, nominato in Apr2019, e ha un mandato di 4.67 anni. la retribuzione annua totale è A$ 660.60K, composta da 60.2% di stipendio e 39.8% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 1.42% delle azioni della società, per un valore di A$ 3.58M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 1.4 anni e 5.6 anni.

Informazioni chiave

Wes Coote

Amministratore delegato

AU$660.6k

Compenso totale

Percentuale dello stipendio del CEO60.2%
Mandato del CEO4.7yrs
Proprietà del CEO1.4%
Durata media del management1.4yrs
Durata media del Consiglio di amministrazione5.6yrs

Aggiornamenti recenti sulla gestione

Recent updates

Calculating The Fair Value Of Healthia Limited (ASX:HLA)

Jan 30
Calculating The Fair Value Of Healthia Limited (ASX:HLA)

Healthia (ASX:HLA) Has Re-Affirmed Its Dividend Of AU$0.02

Mar 02
Healthia (ASX:HLA) Has Re-Affirmed Its Dividend Of AU$0.02

Here's Why Healthia Limited's (ASX:HLA) CEO May Deserve A Raise

Nov 09
Here's Why Healthia Limited's (ASX:HLA) CEO May Deserve A Raise

Earnings Tell The Story For Healthia Limited (ASX:HLA) As Its Stock Soars 30%

Sep 17
Earnings Tell The Story For Healthia Limited (ASX:HLA) As Its Stock Soars 30%

Healthia Limited (ASX:HLA) Stocks Shoot Up 30% But Its P/E Still Looks Reasonable

Sep 17
Healthia Limited (ASX:HLA) Stocks Shoot Up 30% But Its P/E Still Looks Reasonable

Healthia (ASX:HLA) Is Increasing Its Dividend To AU$0.025

Sep 01
Healthia (ASX:HLA) Is Increasing Its Dividend To AU$0.025

I Ran A Stock Scan For Earnings Growth And Healthia (ASX:HLA) Passed With Ease

Aug 17
I Ran A Stock Scan For Earnings Growth And Healthia (ASX:HLA) Passed With Ease

Is Now An Opportune Moment To Examine Healthia Limited (ASX:HLA)?

May 19
Is Now An Opportune Moment To Examine Healthia Limited (ASX:HLA)?

Is Healthia (ASX:HLA) A Risky Investment?

Apr 19
Is Healthia (ASX:HLA) A Risky Investment?

With EPS Growth And More, Healthia (ASX:HLA) Is Interesting

Apr 03
With EPS Growth And More, Healthia (ASX:HLA) Is Interesting

Announcing: Healthia (ASX:HLA) Stock Increased An Energizing 108% In The Last Year

Mar 19
Announcing: Healthia (ASX:HLA) Stock Increased An Energizing 108% In The Last Year

Insider Buying: The Healthia Limited (ASX:HLA) Independent Non-Executive Director Just Bought 4.7% More Shares

Mar 06
Insider Buying: The Healthia Limited (ASX:HLA) Independent Non-Executive Director Just Bought 4.7% More Shares

What Kind Of Shareholders Hold The Majority In Healthia Limited's (ASX:HLA) Shares?

Feb 26
What Kind Of Shareholders Hold The Majority In Healthia Limited's (ASX:HLA) Shares?

Is There Now An Opportunity In Healthia Limited (ASX:HLA)?

Feb 09
Is There Now An Opportunity In Healthia Limited (ASX:HLA)?

Healthia Limited's (ASX:HLA) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Jan 19
Healthia Limited's (ASX:HLA) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Why Dividend Hunters Love Healthia Limited (ASX:HLA)

Dec 29
Why Dividend Hunters Love Healthia Limited (ASX:HLA)

Did You Miss Healthia's (ASX:HLA) 13% Share Price Gain?

Dec 10
Did You Miss Healthia's (ASX:HLA) 13% Share Price Gain?

We're Not So Sure You Should Rely on Healthia's (ASX:HLA) Statutory Earnings

Nov 20
We're Not So Sure You Should Rely on Healthia's (ASX:HLA) Statutory Earnings

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Wes Coote rispetto agli utili di Healthia?
DataCompenso totaleStipendioGuadagni aziendali
Jun 30 2023AU$661kAU$398k

AU$5m

Mar 31 2023n/an/a

AU$3m

Dec 31 2022n/an/a

AU$781k

Sep 30 2022n/an/a

-AU$1m

Jun 30 2022AU$516kAU$345k

-AU$3m

Mar 31 2022n/an/a

-AU$2m

Dec 31 2021n/an/a

AU$161k

Sep 30 2021n/an/a

AU$3m

Jun 30 2021AU$400kAU$306k

AU$5m

Mar 31 2021n/an/a

AU$6m

Dec 31 2020n/an/a

AU$7m

Sep 30 2020n/an/a

AU$5m

Jun 30 2020AU$313kAU$225k

AU$3m

Mar 31 2020n/an/a

AU$1m

Dec 31 2019n/an/a

AU$271k

Sep 30 2019n/an/a

-AU$483k

Jun 30 2019AU$226kAU$176k

-AU$1m

Compensazione vs Mercato: La retribuzione totale di Wes ($USD 439.78K ) è circa la media per le aziende di dimensioni simili nel mercato Australian ($USD 650.58K ).

Compensazione vs guadagni: La retribuzione di Wes è stata coerente con le performance aziendali dell'ultimo anno.


AMMINISTRATORE DELEGATO

Wes Coote

4.7yrs

Mandato

AU$660,599

Compensazione

Mr. Wesley James Coote, also known as Wes, B.Com., C.A., ACIS, serves as the Managing Director of Evolve Salons Limited. Mr. Coote has been Group Managing Director, Chief Executive Officer and Director at...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Wesley Coote
Group MD4.7yrsAU$660.60k1.42%
A$ 3.6m
Damien Peters
Group Chief Financial Officerless than a yearAU$319.83kNessun dato
Darren Stewart
Director of Podiatry & Executive Directorno dataAU$115.34k6.4%
A$ 16.1m
Lisa Roach
Group Chief Partnerships Officer & Executive Directorless than a yearAU$391.84k0.75%
A$ 1.9m
Colin Kangisser
CEO of Eyes & Ears Division and Director2.7yrsAU$368.92k3.66%
A$ 9.2m
Roy Walker
Chief Executive Officer of Bodiesless than a yearAU$314.24kNessun dato
Dean Hartley
Chief Technology Officer1.9yrsAU$261.49k2.49%
A$ 6.3m
Julia Murfitt
General Counsel & Company Secretary1.8yrsNessun datoNessun dato
Anthony Ganter
Group Chief Business Development & Strategy Officerno dataAU$341.32k0%
A$ 0
Kerrie Evans
Group Chief Education & Research Officerno dataNessun datoNessun dato
Aaron Kangisser
Chief Operating Officer of Eyes & Ears Divisionless than a yearNessun datoNessun dato

1.4yrs

Durata media

Gestione esperta: Il team dirigenziale di HLA non è considerato esperto (durata media 1.4 anni), il che suggerisce un nuovo team.


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Wesley Coote
Group MD4.7yrsAU$660.60k1.42%
A$ 3.6m
Darren Stewart
Director of Podiatry & Executive Director5.6yrsAU$115.34k6.4%
A$ 16.1m
Lisa Roach
Group Chief Partnerships Officer & Executive Director1.7yrsAU$391.84k0.75%
A$ 1.9m
Colin Kangisser
CEO of Eyes & Ears Division and Director2.7yrsAU$368.92k3.66%
A$ 9.2m
Glen Richards
Non-Executive Chairman5.6yrsAU$130.00k5.67%
A$ 14.3m
Paul Wilson
Independent Non-Executive Director5.6yrsAU$80.00k2.51%
A$ 6.3m
Lisa Dalton
Independent Non-Executive Director5.6yrsAU$80.00k0.034%
A$ 85.2k

5.6yrs

Durata media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di HLA sono considerati esperti (durata media dell'incarico 5.6 anni).